Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Psychiatric disorders and quality of life in patients with implantable cardioverter defibrillators: a systematic review.

de Ornelas Maia AC, Soares-Filho G, Pereira V, Nardi AE, Silva AC.

Prim Care Companion CNS Disord. 2013;15(2). pii: PCC.12r01456. doi: 10.4088/PCC.12r01456. Epub 2013 Apr 18.

2.

Efficacy of cognitive behavioral therapy in reducing psychiatric symptoms in patients with implantable cardioverter defibrillator: an integrative review.

Maia AC, Braga AA, Soares-Filho G, Pereira V, Nardi AE, Silva AC.

Braz J Med Biol Res. 2014 Apr;47(4):265-72. doi: 10.1590/1414-431X20133418. Epub 2014 Mar 18. Review.

3.

Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.

Palacios-Ceña D, Losa-Iglesias ME, Alvarez-López C, Cachón-Pérez M, Reyes RA, Salvadores-Fuentes P, Fernández-de-Las-Peñas C.

J Adv Nurs. 2011 Dec;67(12):2537-50. doi: 10.1111/j.1365-2648.2011.05694.x. Epub 2011 May 25. Review.

PMID:
21615459
4.

Quality of life and psychological status of patients with implantable cardioverter defibrillators.

Thomas SA, Friedmann E, Kao CW, Inguito P, Metcalf M, Kelley FJ, Gottlieb SS.

Am J Crit Care. 2006 Jul;15(4):389-98. Review.

5.

Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.

Callaghan A, Kendall G, Lock C, Mahony A, Payne J, Verrier L.

Int J Evid Based Healthc. 2005 Jul;3(6):147-67. doi: 10.1111/j.1479-6988.2005.00024.x.

PMID:
21631747
6.

Quality of Life in Patients with an Implantable Cardioverter Defibrillator: A Systematic Review.

Tomzik J, Koltermann KC, Zabel M, Willich SN, Reinhold T.

Front Cardiovasc Med. 2015 Nov 3;2:34. doi: 10.3389/fcvm.2015.00034. eCollection 2015. Review.

7.

The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review.

Magyar-Russell G, Thombs BD, Cai JX, Baveja T, Kuhl EA, Singh PP, Montenegro Braga Barroso M, Arthurs E, Roseman M, Amin N, Marine JE, Ziegelstein RC.

J Psychosom Res. 2011 Oct;71(4):223-31. doi: 10.1016/j.jpsychores.2011.02.014. Epub 2011 Apr 20. Review.

PMID:
21911099
8.

Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.

Ingles J, Sarina T, Kasparian N, Semsarian C.

Int J Cardiol. 2013 Oct 9;168(4):3779-84. doi: 10.1016/j.ijcard.2013.06.006. Epub 2013 Jul 5.

PMID:
23835269
9.

The effects of age on quality of life in implantable cardioverter defibrillator recipients.

Hamilton GA, Carroll DL.

J Clin Nurs. 2004 Feb;13(2):194-200.

PMID:
14723671
10.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

11.

ICD: a qualitative study of patient experience the first year after implantation.

Kamphuis HC, Verhoeven NW, Leeuw R, Derksen R, Hauer RN, Winnubst JA.

J Clin Nurs. 2004 Nov;13(8):1008-16.

PMID:
15533107
12.

Psychological effects of implantable cardioverter defibrillator shocks. A review of study methods.

Manzoni GM, Castelnuovo G, Compare A, Pagnini F, Essebag V, Proietti R.

Front Psychol. 2015 Feb 4;6:39. doi: 10.3389/fpsyg.2015.00039. eCollection 2015. Review.

13.

Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients.

Flemme I, Johansson I, Strömberg A.

J Clin Nurs. 2012 Feb;21(3-4):311-21. doi: 10.1111/j.1365-2702.2011.03847.x. Epub 2011 Sep 26.

PMID:
21951323
14.

Evaluation of an education and follow-up programme for implantable cardioverter defibrillator-implanted patients.

Cinar FI, Tosun N, Kose S.

J Clin Nurs. 2013 Sep;22(17-18):2474-86. doi: 10.1111/jocn.12201. Epub 2013 Apr 3.

PMID:
23551749
15.

Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.

Hill L, McIlfatrick S, Taylor B, Dixon L, Harbinson M, Fitzsimons D.

Palliat Med. 2015 Apr;29(4):310-23. doi: 10.1177/0269216314550374. Epub 2014 Sep 19. Review.

PMID:
25239128
16.

Sexual dysfunction and cardiovascular diseases: a systematic review of prevalence.

Nascimento ER, Maia AC, Pereira V, Soares-Filho G, Nardi AE, Silva AC.

Clinics (Sao Paulo). 2013 Nov;68(11):1462-8. doi: 10.6061/clinics/2013(11)13. Review.

17.

Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.

Thylén I, Dekker RL, Jaarsma T, Strömberg A, Moser DK.

J Psychosom Res. 2014 Aug;77(2):122-7. doi: 10.1016/j.jpsychores.2014.05.007. Epub 2014 Jun 2.

PMID:
25077853
18.

Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator.

Godemann F, Butter C, Lampe F, Linden M, Schlegl M, Schultheiss HP, Behrens S.

Clin Cardiol. 2004 Jun;27(6):321-6.

19.

An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life.

Bostwick JM, Sola CL.

Psychiatr Clin North Am. 2007 Dec;30(4):677-88. Review.

PMID:
17938040
20.

Classic conditioning and dysfunctional cognitions in patients with panic disorder and agoraphobia treated with an implantable cardioverter/defibrillator.

Godemann F, Ahrens B, Behrens S, Berthold R, Gandor C, Lampe F, Linden M.

Psychosom Med. 2001 Mar-Apr;63(2):231-8.

PMID:
11292270
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk